By: Wayne Turner, Abigail Coursolle, and Sarah Grusin
Executive Summary
The National Health Law Program filed an amicus brief with the United States Supreme Court asking it to review a 4th Circuit decision that struck down Maryland’s anti-price gouging law for prescription drugs as unconstitutional. The brief focuses on the impact of high drug costs on low-income people and the health system broadly. It was joined by AARP and AARP Foundation, Disability Rights Maryland, Families USA, Justice in Aging, Knowledge Ecology International, Maryland Citizens’ Health Initiative, and Public Citizen.
